X
Xueying Yan
Researcher at Heilongjiang University of Chinese Medicine
Publications - 16
Citations - 986
Xueying Yan is an academic researcher from Heilongjiang University of Chinese Medicine. The author has contributed to research in topics: Photothermal therapy & Mesoporous silica. The author has an hindex of 9, co-authored 13 publications receiving 853 citations.
Papers
More filters
Journal ArticleDOI
Multifunctional Mesoporous Silica-Coated Graphene Nanosheet Used for Chemo-Photothermal Synergistic Targeted Therapy of Glioma
TL;DR: These findings provided an excellent drug delivery system for combined therapy of glioma due to the advanced chemo-photothermal synergistic targeted therapy and good drug release properties of GSPID, which could effectively avoid frequent and invasive dosing and improve patient compliance.
Journal ArticleDOI
Photothermal combined gene therapy achieved by polyethyleneimine-grafted oxidized mesoporous carbon nanospheres.
Ying Meng,Shanshan Wang,Chengyi Li,Min Qian,Xueying Yan,Shuangchao Yao,Xiyue Peng,Yi Wang,Rongqin Huang +8 more
TL;DR: Polyethyleneimine-grafted oxidized mesoporous carbon nanospheres (OP) was developed for combined photothermal combined gene therapy in vitro and in-vivo and suggested the OP's potential for cancer therapy.
Journal ArticleDOI
Specific aptamer-conjugated mesoporous silica-carbon nanoparticles for HER2-targeted chemo-photothermal combined therapy.
TL;DR: Findings suggested that MSCN-PEG-HB5/DOX was a potential chemo-photothermal therapeutic platform targeting to HER2-positive breast cancers.
Journal ArticleDOI
Synthesis of Core–Shell Graphitic Carbon@Silica Nanospheres with Dual-Ordered Mesopores for Cancer-Targeted Photothermochemotherapy
Yi Wang,Kaiyuan Wang,Ren Zhang,Xingang Liu,Xueying Yan,Jianxin Wang,Ernst Wagner,Rongqin Huang +7 more
TL;DR: The MMPSD system exhibited efficient drug loading capacity, high targeting ability, sensitive NIR/pH-responsive DOX release, sustained release, and excellent combined antitumor activity.
Journal ArticleDOI
Enhanced blood–brain barrier penetration and glioma therapy mediated by a new peptide modified gene delivery system
Hui Yao,Kaiyuan Wang,Yi Wang,Shanshan Wang,Jianfeng Li,Jinning Lou,Liya Ye,Xueying Yan,Weiyue Lu,Rongqin Huang +9 more
TL;DR: The results demonstrated that LNP is a kind of efficient CPPs especially for BBB-crossing application, and DGL-PEG-LNP/DNA is a potential non-viral platform for glioma gene therapy via intravenous administration.